Zolmitriptan Tablet, Orally Disintegrating
Product Images NDC 62332-181

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 62332-181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1.jpg (Zolmitriptan Figure1)

A line graph comparing the estimated probability of response over time (0 to 4 hours) from the initial dose for placebo and Zolmitriptan tablets at doses of 1 mg, 2.5 mg, and 5 mg. The graph shows increasing response probability with higher doses over the 4-hour period.*

FDA Label Image

Zolmitriptan-figure2.jpg (Zolmitriptan Figure2)

A line graph showing the estimated probability of remediation or rescue medication over 24 hours following an initial dose. The graph compares four groups: placebo, 1 mg, 2.5 mg, and 5 mg dosages, with probability increasing over time across all groups.*

FDA Label Image

Fig-3.jpg (Zolmitriptan Figure3)

This is a line graph showing the estimated probability of response over time from the initial dose for Zolmitriptan Orally Disintegrating Tablets 2.5 mg compared to placebo. The x-axis represents time in hours (0 to 2), and the y-axis shows the estimated probability of response from 0% to 100%. The Zolmitriptan line rises more steeply than placebo, reaching about 65% response at 2 hours, while placebo reaches about 28%.*

FDA Label Image

Fig-4.jpg (Zolmitriptan Figure4)

A line graph comparing estimated probability of remediation or rescue over 24 hours between placebo and Zolmitriptan Orally Disintegrating Tablets 2.5 mg. The graph shows time in hours from initial dose on the x-axis and estimated probability on the y-axis, with placebo depicted as a dashed line and zolmitriptan as a solid line.*

FDA Label Image

6 (1 X 6) Unit Dose Tablets (Zolmitriptan mg 25)

Packaging label for Zolmitriptan Orally Disintegrating Tablets USP 2.5 mg by Alembic Pharmaceuticals Inc. The label indicates a unit dose package of 6 tablets (1 x 6), marked Rx only, with barcodes and storage instructions. The product name and strength are prominently displayed in red and black text.*

FDA Label Image

3 (1 X 3) Unit Dose Tablets (Zolmitriptan mg 5)

Packaging label for Zolmitriptan Orally Disintegrating Tablets, USP, 5 mg strength. The label shows a carton designed to hold 3 unit dose tablets (1x3) by Alembic Pharmaceuticals Inc. It includes dosage strength in blue boxes, NDC number 62332-182-03, barcodes, and storage instructions. The label states the product is Rx only.*

FDA Label Image

Structure (Zolmitriptan Str)

Chemical structure diagram of zolmitriptan, showing its molecular connectivity including a fused bicyclic system and functional groups relevant to its pharmacological activity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.